tiprankstipranks
Trending News
More News >

Rhythm Biosciences Announces New Securities Quotation on ASX

Story Highlights
Rhythm Biosciences Announces New Securities Quotation on ASX

Don’t Miss TipRanks’ Half-Year Sale

Rhythm Biosciences Ltd. ( (AU:RHY) ) just unveiled an update.

Rhythm Biosciences Ltd. has announced the application for quotation of 483,871 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective June 2, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting its operations and stakeholder interests positively.

More about Rhythm Biosciences Ltd.

Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company is primarily engaged in creating products that aid in the early detection of diseases, with a market focus on enhancing healthcare outcomes through innovative solutions.

Average Trading Volume: 231,399

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$18.84M

Learn more about RHY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1